Results 201 to 210 of about 30,028 (235)

Heterozygous familial hypercholesterolemia case study

Journal of the American Academy of Nurse Practitioners, 2010
Abstract  Purpose: To examine a case of heterozygous familial hypercholesterolemia (HeFH) in a primary care setting and to review the epidemiology, pathophysiology, etiology, and treatment guidelines to reduce the mortality related to this disease process. Data Sources: Findings from the history, physical exam, and laboratory results of a young French
openaire   +2 more sources

Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis

Angiology, 2019
Heterozygous familial hypercholesterolemia (HeFH) is a common genetic disorder predisposing affected individuals to lifelong low-density lipoprotein cholesterol (LDL-C) elevation and coronary heart disease.
L. Akioyamen, J. Tu, J. Genest, Dennis T. Ko, Alexandre Coutin, S. Shan, A. Chu   +6 more
semanticscholar   +1 more source

Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.

Atherosclerosis, 2019
A large number of epidemiological studies in ethnically diverse populations show that lipoprotein(a) [Lp(a)] levels above 30-50 mg/dL are significantly associated with calcific aortic valve stenosis, although less so in African Americans.
A. Vuorio, G. Watts, P. Kovanen
semanticscholar   +1 more source

Effect of quantitative and qualitative diet prescription on children behavior after diagnosis of heterozygous familial hypercholesterolemia.

International Journal of Cardiology, 2019
BACKGROUND Diet and healthy modifications in lifestyle represent the first therapeutic approach for early intervention in hypercholesterolemia. We aimed to evaluate the impact of a qualitative dietetic program rather than a quantitative one on metabolic ...
A. Cicero, F. Fogacci, M. Giovannini, M. Bove, G. Debellis, C. Borghi   +5 more
semanticscholar   +1 more source

Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment

Current Opinion in Lipidology, 2019
Purpose of review To discuss the heterogeneity of atherosclerotic cardiovascular disease (ASCVD) risk in heterozygous familial hypercholesterolemia and evidence and limitations of clinical risk scores and subclinical coronary atherosclerosis (SCA ...
M. Miname, M. Bittencourt, K. Nasir, R. Santos   +3 more
semanticscholar   +1 more source

Treatment of heterozygous familial hypercholesterolemia: atorvastatin versus simvastatin

Atherosclerosis Supplements, 2001
This study compares the cholesterol-lowering efficacy of atorvastatin and simvastatin in attainment of the National Cholesterol Education Program (NCEP) guidelines LDL-cholesterol (LDL-C) goal in patients with heterozygous familial hypercholesterolemia (HFH).
M, Bo, M T, Nicolello, U, Fiandra, G, Mercadante, T, Piliego, F, Fabris   +5 more
openaire   +2 more sources

Stress testing response in women heterozygous for familial hypercholesterolemia

International Journal of Cardiology, 2007
We evaluated 62 exercise treadmill tests (ETTs) in equal numbers of heterozygous for familial hypercholesterolemia (hFH) and healthy (HLY) women, matched for age, baseline systolic and diastolic blood pressure (BP) and baseline heart rate (HR), using the Bruce protocol.
Genovefa D, Kolovou, Dimitris S, Damaskos, Katherine K, Anagnostopoulou, Klelia D, Salpea, Athanasios, Dritsas, Vasiliki, Giannakopoulou, Ioannis K, Vasiliadis, Dennis V, Cokkinos   +7 more
openaire   +2 more sources

Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia

Current Atherosclerosis Reports, 2022
A. Gallo, Reed Mszar, M. Miname
semanticscholar   +1 more source

Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy.

Journal of Clinical Lipidology, 2018
BACKGROUND A large proportion of patients with heterozygous familial hypercholesterolemia (heFH) do not reach low-density lipoprotein cholesterol (LDL-c) levels advocated by international guidelines (
M. Hartgers, J. Besseling, E. Stroes, Janneke Wittekoek, J. Rutten, J. de Graaf, F. Visseren, B. Imholz, J. Roeters van Lennep, R. Huijgen, J. Kastelein, G. Hovingh   +11 more
semanticscholar   +1 more source

Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.

Journal of Psychosomatic Research, 2018
BACKGROUND Heterozygous familial hypercholesterolemia (FH) is a common genetic disease predisposing affected individuals to a high risk of cardiovascular disease.
L. Akioyamen, J. Genest, S. Shan, Happy Inibhunu, A. Chu, J. Tu   +5 more
semanticscholar   +1 more source